AU613884B2 - 8-substituted 2-aminotetralins - Google Patents

8-substituted 2-aminotetralins Download PDF

Info

Publication number
AU613884B2
AU613884B2 AU83029/87A AU8302987A AU613884B2 AU 613884 B2 AU613884 B2 AU 613884B2 AU 83029/87 A AU83029/87 A AU 83029/87A AU 8302987 A AU8302987 A AU 8302987A AU 613884 B2 AU613884 B2 AU 613884B2
Authority
AU
Australia
Prior art keywords
denotes
alkyl
hydrogen
cyano
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU83029/87A
Other languages
English (en)
Other versions
AU8302987A (en
Inventor
George S. Allen
Thomas Glaser
Bodo Junge
Bernd Richter
Jorg Traber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU8302987A publication Critical patent/AU8302987A/en
Application granted granted Critical
Publication of AU613884B2 publication Critical patent/AU613884B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU83029/87A 1986-12-22 1987-12-22 8-substituted 2-aminotetralins Ceased AU613884B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3643899 1986-12-22
DE3643899 1986-12-22
DE3719924 1987-06-15
DE19873719924 DE3719924A1 (de) 1986-12-22 1987-06-15 8-substituierte 2-aminotetraline

Publications (2)

Publication Number Publication Date
AU8302987A AU8302987A (en) 1988-06-30
AU613884B2 true AU613884B2 (en) 1991-08-15

Family

ID=25850693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83029/87A Ceased AU613884B2 (en) 1986-12-22 1987-12-22 8-substituted 2-aminotetralins

Country Status (14)

Country Link
US (3) US4873262A (hu)
EP (1) EP0272534A3 (hu)
JP (1) JP2596956B2 (hu)
KR (1) KR880007432A (hu)
CN (1) CN87101285A (hu)
AU (1) AU613884B2 (hu)
DE (1) DE3719924A1 (hu)
DK (1) DK675787A (hu)
FI (1) FI875598A (hu)
HU (1) HUT46653A (hu)
IL (1) IL84875A0 (hu)
NO (1) NO167282C (hu)
NZ (1) NZ222977A (hu)
PT (1) PT86425B (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634366B2 (en) * 1990-03-21 1993-02-18 Merrell Dow Pharmaceuticals Inc. Novel 8-sulfamylmethylene-2-amino tetralins

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
US4927955A (en) * 1987-08-12 1990-05-22 Sanofi Process for the O-alkylation of N-(hydroxy)aralkylphenylethanolamines
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
US5162375A (en) * 1988-05-06 1992-11-10 Beecham Group P.L.C. Treatment of neuronal degeneration with 5HT1A agonists
GB8810748D0 (en) * 1988-05-06 1988-06-08 Beecham Wuelfing Gmbh & Co Kg Novel treatment
KR910700225A (ko) * 1989-01-09 1991-03-14 로버트 에이. 아미테이지 할로 치환된 아미노테트랄린
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
CA1335106C (en) * 1989-02-27 1995-04-04 John Mehnert Schaus Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
IL109647A (en) * 1989-02-27 1997-04-15 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetra- hydronaphthalenes and 3-aminochromanes
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
HUT61719A (en) * 1989-05-31 1993-03-01 Upjohn Co Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds
US5545755A (en) * 1989-05-31 1996-08-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
DE3919624A1 (de) * 1989-06-15 1990-12-20 Boehringer Ingelheim Kg Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5486611A (en) * 1989-07-13 1996-01-23 The Upjohn Company Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives
DK0482084T3 (da) * 1989-07-13 1997-11-03 Upjohn Co (1,2N)- og (3,2N)-carbocyklisk-2-amino-tetralin-derivater.
DE3924365A1 (de) * 1989-07-22 1991-01-24 Boehringer Ingelheim Kg 2-amino-7-carbamoyl-1,2,3,4- tetrahydronaphthaline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
CA2071897A1 (en) * 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
US5194439A (en) * 1990-04-06 1993-03-16 John Wyeth & Brother Limited N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
DE69124868T2 (de) * 1990-08-15 1997-07-10 Lilly Co Eli Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane
US5252586A (en) * 1990-09-28 1993-10-12 The Du Pont Merck Pharmaceutical Company Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents
DK0712837T3 (da) * 1991-02-08 2000-11-20 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphtalener og 3-aminochromaner
WO1992021654A2 (en) * 1991-05-20 1992-12-10 The Upjohn Company Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
JP3155276B2 (ja) * 1991-05-20 2001-04-09 ファルマシア・アンド・アップジョン・カンパニー カルボキサミド−（１，２ｎ）−カルボサイクリック−２−アミノテトラリン誘導体
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
US5288749A (en) * 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
FR2686339B1 (fr) * 1992-01-22 1994-03-11 Adir Cie Nouveaux amides et sulfonamides naphtaleniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5194658A (en) * 1992-03-02 1993-03-16 The Dow Chemical Company Process for making 2-amino-3-methyl-1-naphthalenecarbonitrile
EP0714292A4 (en) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc SIGMA RECEPTOR LIGANDS AND THEIR USE
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
FR2711140B1 (fr) * 1993-10-12 1996-01-05 Sanofi Sa 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
GB9420529D0 (en) * 1994-10-12 1994-11-30 Pfizer Ltd Indoles
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CZ370198A3 (cs) * 1996-05-31 1999-05-12 Pharmacia & Upjohn Company Aryl substituované cyklické aminy jako selektivní dopaminové D3 ligandy
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) * 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CA2288897A1 (en) * 1997-04-30 1998-11-05 Clint Duane Walker Aminotetralins as 5-ht1d.alpha. agonists
US6355674B1 (en) 1997-04-30 2002-03-12 Eli Lilly And Company Aminotetralins as 5-HT1D α Agonists
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US20100006191A1 (en) * 2008-07-09 2010-01-14 Brush Wellman, Inc. HIGH STRENGTH Be/Cu ALLOYS WITH IMPROVED ELECTRICAL CONDUCTIVITY
DE102010020553A1 (de) 2010-05-14 2011-11-17 Bayer Schering Pharma Aktiengesellschaft Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
CA2879456A1 (en) 2012-07-20 2014-01-23 Bayer Pharma Aktiengesellschaft Substituted aminoindane- and aminotetralincarboxylic acids and use thereof
CN104822661B (zh) 2012-07-20 2017-05-31 拜耳药业股份公司 5‑氨基四氢喹啉‑2‑羧酸及其用途
WO2019037791A1 (zh) * 2017-08-25 2019-02-28 广州市恒诺康医药科技有限公司 一种长效雷沙吉兰前药及其制备方法和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7619787A (en) * 1986-07-28 1988-02-04 Whitby Research, Inc. Substituted 2-aminotetralins
AU8241787A (en) * 1986-12-10 1988-06-16 Bayer Aktiengesellschaft Substituted basic 2-aminotetralins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407198A1 (fr) * 1977-10-27 1979-05-25 Torii & Co Ltd Esters amino- ou guanidino-1, 2, 3, 4-tetrahydro-1-naphtoiques
DE2803582A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
DE3271003D1 (en) * 1981-09-15 1986-06-12 Ici Plc Amino-substituted tetralins and related homocyclic compounds
DE3371070D1 (en) * 1982-09-07 1987-05-27 Yoshitomi Pharmaceutical 4-amino-tetrahydro-2-naphthoic acid derivatives
US4510157A (en) * 1982-12-27 1985-04-09 Ayerst, Mckenna & Harrison, Inc. 6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7619787A (en) * 1986-07-28 1988-02-04 Whitby Research, Inc. Substituted 2-aminotetralins
AU8241787A (en) * 1986-12-10 1988-06-16 Bayer Aktiengesellschaft Substituted basic 2-aminotetralins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634366B2 (en) * 1990-03-21 1993-02-18 Merrell Dow Pharmaceuticals Inc. Novel 8-sulfamylmethylene-2-amino tetralins

Also Published As

Publication number Publication date
NO167282C (no) 1991-10-23
US4968679A (en) 1990-11-06
KR880007432A (ko) 1988-08-27
IL84875A0 (en) 1988-06-30
US5047422A (en) 1991-09-10
CN87101285A (zh) 1988-08-17
HUT46653A (en) 1988-11-28
AU8302987A (en) 1988-06-30
NO875005D0 (no) 1987-12-01
DK675787A (da) 1988-06-23
FI875598A0 (fi) 1987-12-18
FI875598A (fi) 1988-06-23
EP0272534A2 (de) 1988-06-29
NO167282B (no) 1991-07-15
PT86425B (pt) 1990-11-20
NZ222977A (en) 1990-07-26
NO875005L (no) 1988-06-23
DE3719924A1 (de) 1988-06-30
EP0272534A3 (de) 1989-07-26
PT86425A (en) 1988-01-01
JPS63190857A (ja) 1988-08-08
DK675787D0 (da) 1987-12-21
JP2596956B2 (ja) 1997-04-02
US4873262A (en) 1989-10-10

Similar Documents

Publication Publication Date Title
AU613884B2 (en) 8-substituted 2-aminotetralins
AU625817B2 (en) 1,3-disubstituted pyrrolidines
US5026857A (en) Substituted basic 2-aminotetralin in pharmaceuticals
EP0729457B1 (en) Diaminocyclobutene-3,4-diones as smooth muscle relaxants
US20030153596A1 (en) Novel thiourea derivatives and the pharmaceutical compositions containing the same
JPS5989625A (ja) 芳香族置換環状アミジン止瀉剤
US4118417A (en) Process for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acids
US5506252A (en) Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
US5021438A (en) 1,3,4,5-tetrahydrobenz(c,d)indoles
JP3323420B2 (ja) ベンズイミダゾール誘導体
PL134491B1 (en) Process for preparing novel 2-guanidine-4-heteroarylothiazoles
CA1077488A (en) Phenylethanolamines
CA1100959A (en) Indolo (2,3-a) quinolizidines, preparation and therapeutic use
JPH08268983A (ja) 中間体として有用なアニリン誘導体
US5250540A (en) Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments
US3317545A (en) [2-(2, 6-dimethylpiperidino)ethyl]guanidines and intermediates
EP0585116B1 (en) 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor
US3997608A (en) N-substituted-dihydroxyphenethylamines
JP2001502663A (ja) 置換バリンアミド誘導体の製造方法
HU202506B (en) Process for producing benzoxazolone derivatives
EP0185368B1 (en) Aminobenzamide derivatives
US4904816A (en) Process for the manufacture of anilinofumarate via chloromaleate or chlorofumarate or mixtures thereof
JPS6360750B2 (hu)
US4374067A (en) Intermediates for the preparation of 4-phenyl-1,3-benzodiazepins and methods for preparing the intermediates
KR890000419B1 (ko) 엔카이니드의 제조 방법